why choose us

First received: January 10, 2023

Clinical Trial: A Rollover Study of CC-122

Study Status: Completed

Recruit Status: RECRUITING

Condition: Non-Hodgkin Lymphoma

Study Type: INTERVENTIONAL


Official Title: Continuing Treatment for Participants Who Have Participated in a Prior Protocol Investigating CC-122

Brief Summary: The purpose of the study is to provide CC-122 treatment to participants who have been receiving treatment in other CC-122 clinical trials investigating CC-122 for more than 5 years (CC-122-ST-001 [NCT01421524], CC-122-ST-002 [NCT02509039], CC-122-DBCL-001 [NCT02031419], and CC-122-NHL-001 [NCT02417285]), receiving clinical benefit from the treatment and to monitor the safety and tolerability of CC-122.

Read more